Close Menu
    National News Brief
    Monday, November 16
    • Home
    • Business
    • Lifestyle
    • Science
    • Technology
    • International
    • Arts & Entertainment
    • Sports
    National News Brief
    Home » What you need to know about mRNA vaccines in light of RFK’s claims

    What you need to know about mRNA vaccines in light of RFK’s claims

    Team_NationalNewsBriefBy Team_NationalNewsBriefAugust 7, 2025 Science No Comments4 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Robert F Kennedy Jr, the head the US health department

    ZUMA Press, Inc./Alamy

    The US health secretary claimed mRNA vaccines are ineffective against respiratory diseases, while announcing he was cutting half a billion dollars in funding for mRNA vaccine development. But this goes against the scientific evidence we have, which shows many mRNA vaccines work as well as – or better than – other types of vaccine. Here is what you need to know to assess these claims.

    In announcing the cuts, the head of the US Department of Health and Human Services, Robert F Kennedy Jr, claimed  “these vaccines fail to protect effectively against upper respiratory infections like COVID and flu”. Kennedy said the agency would shift funding “toward safer, broader vaccine platforms that remain effective even as viruses mutate”.

    There is now a wide range of vaccine types: live viruses, killed viruses, genetically engineered viral shells, single viral proteins and mRNAs coding for viral proteins. The effectiveness of all of these kinds of vaccines often has a lot more to do with the nature of the virus being targeted than the vaccine itself.

    For instance, the MMR vaccine can be 100 per cent effective at preventing measles outbreaks if more than about 90 per cent of a population is vaccinated. But the measles virus is an easy target because it does not change much and it takes a convoluted route deep inside the body, meaning there are plenty of opportunities for the immune system to intercept it before people develop symptoms or become infectious.

    In contrast, the respiratory viruses that cause colds and flus first infect the cells lining the nose and throat. It is hard to generate high levels of effective antibodies in these membranes, so it is much more difficult to prevent infections and onward transmission than with measles.

    Additionally, cold, flu and covid-19 viruses are constantly mutating, and there is strong evolutionary selection for any mutations that help a virus dodge the immune protection generated by infections or vaccinations. For this reason, no flu or covid-19 vaccine of any type provides the same lifelong protection as the measles component of the MMR vaccine. But the mRNA ones do work relatively well.

    For instance, some mRNA covid-19 vaccines were more than 90 per cent effective against symptomatic infections, with even higher protection against severe disease. For comparison, the effectiveness of the non-mRNA vaccines used to protect from the annual flu varies from 20 to 60 per cent. And in a recent trial, a combined covid-flu mRNA vaccine outperformed existing, non-mRNA flu vaccines in people aged over 50 – those who most need protection.

    So Kennedy’s claim of a lack of efficacy is nonsense. This is not to say mRNA vaccines are always better than other types. But new vaccines have to outperform older ones in trials – mRNA shots won’t get approved if they are not better.

    Kennedy also claims other kinds of vaccines are more likely to remain effective as viruses mutate. This seems to be a reference to developing “universal vaccines” – a single vaccine that is effective against all flu viruses, say, or one that works against all coronaviruses. The idea is to target the outer parts of viruses that don’t change. But this is hard to do because viruses tend to hide their unchanging parts under the parts that do change.

    Efforts to develop effective universal vaccines have so far failed, despite decades of efforts, so focusing too much funding on them could be a mistake. What is more, mRNA technology can, and already has, been used to create experimental universal vaccines. So the second part of Kennedy’s statement is also nonsense.

    Last but not least, efficacy isn’t everything. Safety, cost and the speed of vaccine development are crucial, too. Here mRNA technology has some huge advantages. It is safer than vaccines consisting of actual viruses, cheaper than vaccines consisting of a single viral protein and can be developed much faster than either type – which is important with fast-changing respiratory viruses, especially in a pandemic situation.

    In addition, the technology in mRNA vaccines could be used more broadly to develop a huge range of other treatments. The funding cuts announced by Kennedy on the basis of his false claim could slow development by deterring companies from investing in this approach.

    Topics:



    Source link

    Team_NationalNewsBrief
    • Website

    Keep Reading

    The neuroscience behind stuttering | Scientific American

    Record-breaking simulation sheds light on cosmic ‘dark ages’

    Why your brain sometimes craves sour tastes

    The Euclid space telescope captures nearly a billion celestial objects in stunning detail

    Scientists might have discovered what makes AI so effective at chess

    We beat screwworm once. Here’s how we’re trying to do it again

    Add A Comment

    Comments are closed.

    Editors Picks

    Steelers may have an obvious replacement for Aaron Rodgers

    March 23, 2026

    As Islamophobia ramps up in US midterms, Texas Muslims eye local stakes | US Midterm Elections 2026 News

    November 2, 2026

    Opinion | A Simple Fix to Curb Federal Power

    February 7, 2026

    India Buys Oil On Price, Not Political Loyalty

    October 12, 2026

    West Nile virus detected in mosquitoes in the UK for the first time

    May 21, 2025
    Categories
    • Arts & Entertainment
    • Business
    • International
    • Latest News
    • Lifestyle
    • Opinions
    • Politics
    • Science
    • Sports
    • Technology
    • Top Stories
    • Trending News
    • World Economy
    About us

    Welcome to National News Brief, your one-stop destination for staying informed on the latest developments from around the globe. Our mission is to provide readers with up-to-the-minute coverage across a wide range of topics, ensuring you never miss out on the stories that matter most.

    At National News Brief, we cover World News, delivering accurate and insightful reports on global events and issues shaping the future. Our Tech News section keeps you informed about cutting-edge technologies, trends in AI, and innovations transforming industries. Stay ahead of the curve with updates on the World Economy, including financial markets, economic policies, and international trade.

    Editors Picks

    How Sam Bankman-Fried Lost Out on a $35 Billion Jackpot From Anthropic

    November 16, 2026

    Ireland Refuses To Hunt Down Men For Zelensky

    November 16, 2026

    Connecticut’s Top 5 High School Football Plays, Weeks 9-10

    November 16, 2026

    Taylor Swift’s Lawyers Fire Back In Bitter Showgirl War

    November 16, 2026
    Categories
    • Arts & Entertainment
    • Business
    • International
    • Latest News
    • Lifestyle
    • Opinions
    • Politics
    • Science
    • Sports
    • Technology
    • Top Stories
    • Trending News
    • World Economy
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About us
    • Contact us
    Copyright © 2024 Nationalnewsbrief.com All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.